<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13513-bib-0013">
 <label>13</label>
 <mixed-citation publication-type="journal" id="cas13513-cit-0013">
  <string-name>
   <surname>Zinzani</surname>
   <given-names>PL</given-names>
  </string-name>, 
  <string-name>
   <surname>Karlin</surname>
   <given-names>L</given-names>
  </string-name>, 
  <string-name>
   <surname>Radford</surname>
   <given-names>J</given-names>
  </string-name>, et al. 
  <article-title>European phase II study of mogamulizumab, an anti‐CCR4 monoclonal antibody, in relapsed/refractory peripheral T‐cell lymphoma</article-title>. 
  <source>Haematologica</source>. 
  <year>2016</year>;
  <volume>101</volume>:
  <fpage>e407</fpage>‐
  <lpage>e410</lpage>.
  <pub-id pub-id-type="pmid">27418646</pub-id>
 </mixed-citation>
</ref>
